Bundled "Longevity Panels" / Executive Health Packages
Last reviewed 25 August 2026 · Evidence-graded review — see Methodology
Pre-packaged bundles combining dozens of the tests above, typically mixing genuinely Strong ones — CBC, lipids, HbA1c — with Weak or Emerging ones such as an epigenetic clock, full-body MRI or microbiome test, under a single premium price that can run to S$3,000–15,000+. Bundling does not average out the evidence quality of its components: a package is only as trustworthy as its weakest constituent test. The framing works against the evidence too, since “comprehensive” and “leave no stone unturned” describe precisely the strategy that, in a low-pretest-probability population, increases false positives, incidental findings, downstream anxiety and unnecessary follow-up procedures without a proven mortality or morbidity benefit.
No published trial evidence shows that any specific “longevity panel” bundle, as a package, improves mortality or morbidity outcomes compared with guideline-based, risk-stratified testing. A Cochrane systematic review of general health checks in adults (Krogsbøll et al., PMID 30699470, 15 RCTs, more than 250,000 participants) found no reduction in all-cause, cardiovascular or cancer mortality from inviting asymptomatic adults to general health checks. The individual components should be evaluated — and paid for — on their own evidence, not on the appeal of the bundle.
Singapore guidance
Not covered in the current review
Singapore’s national screening committee has not reviewed this test in the current volume of its report, which covers nine conditions. That is not a verdict either way.
Source: Screening Test Review Committee report 2026, Volume 1 (Academy of Medicine Singapore and Ministry of Health, February 2026). The full national list · How this is used.
What you would actually pay
- Healthier SG
- Not subsidised
- MediSave
- Not among the screenings named for outpatient claims
Source: Healthier SG Screening (HealthHub) and MediSave outpatient care (Ministry of Health). Absence from either list is not a statement that the test is discouraged — only that no subsidy or claim applies. Gross prices compared.
What it costs when it is wrong
- Basis
- No published harm criterion found
- Severity
- Not documented
Not covered in the current volume of the committee’s report, so no harm criterion was found either way.
An empty finding, not a clean bill of health: this means nothing documented was found for this test. It is not a claim that the test is safe.
Screening harm is not only a laboratory question: the committee’s own criteria advise against a test when “the screening test, or follow-up tests arising from a positive screen, are associated with significant medical risks”. Sources on overdiagnosis → · How this is graded.
Singapore pricing. We have a full price breakdown for this test, using checked 2026 figures from named providers — read the price guide →
FAQ
Is the Bundled "Longevity Panels" / Executive Health Packages worth doing in Singapore?
Judged for screening an asymptomatic adult, Bundled "Longevity Panels" / Executive Health Packages grades weak (as a bundle) on our rubric. It typically costs S$3,000–15,000 in Singapore. It is most appropriate for not recommended as a default purchase — build a testing plan from individual test grades instead. There is no routine interval: .
Weighing this against something else? Compare it with two other tests → · Price it inside a panel →